wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C
Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C
HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer
P2860
Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33686182-50B89328-844F-441E-9D02-CAE7C8480D4C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36d0291ecd794cabe4ecdb4cf3fb6b845cbb79c5
P2860
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.